Headlines

Imaging technique allows pediatric brain tumors to be classified noninvasively at diagnosis

Researchers have discovered that determining a tumor's medulloblastoma subgroup can be achieved noninvasively, using magnetic resonance spectroscopy (MRS).

Antibiotic use was associated with increased risk for some cancers

Antibiotic use was associated with increased risk for some cancers

Recurrent exposure to antibiotics may increase the risk for cancer in specific organ sites.

ADT impacts mood of patients with prostate cancer, as perceived by partners

ADT impacts mood of patients with prostate cancer, as perceived by partners

Androgen deprivation therapy negative impacts the mood of patients with prostate cancer.

Varubi approved for nausea and vomiting associated with cancer chemo

Varubi approved for nausea and vomiting associated with cancer chemo

The FDA for the prevention of highly emetogenic and moderately emetogenic chemotherapy-induced nausea and vomiting.

Higher frequency of BRCA mutations observed in black women

Higher frequency of BRCA mutations observed in black women

In a study reviewing black women under 50 with invasive breast cancer, 12 percent had BRCA1 or BRCA2 mutations.

Genetic test helps identify risk for more aggressive disease, improving myeloma treatment

New research has identified as few as nine genetic features would need to be tested to identify high-risk patients who might benefit from intensive myeloma treatment.

Two-cycle technique improves determining optimal treatment doses in clinical trials

A new technique has been developed by statisticians to help doctors optimize dosing new cancer treatments in phase I/II clinical trials.

Synchronous resection of primary colorectal tumor, liver metastases safe in some patients

Synchronous resection of primary colorectal tumor, liver metastases safe in some patients

Patient outcomes associated with synchronous and sequential colorectal and liver resections in patients with stage IV colorectal cancer.

Prostate cancer not likely to be cause of death in men with low-risk disease

Prostate cancer not likely to be cause of death in men with low-risk disease

Relatively unaggressive prostate tumors are not likely to develop into metastatic disease or result in death.

Among patients with myeloma undergoing chemo, high exercise compliance linked with reduced fatigue

Among patients with myeloma undergoing chemo, high exercise compliance linked with reduced fatigue

Among patients with multiple myeloma, high compliance with exercise was associated with improvements in fatigue.

Conference Coverage

PET-adapted treatment improves outcomes for patients with stage I/II Hodgkin lymphoma

Early FDG-PET adapted treatment improves the outcome of early FDG-PET-positive patients with stages I/II Hodgkin lymphoma, according to the results of a randomized trial.

Managing oral oncology/hematology treatments in your practice

An increasing number of oncology/hematology treatments will consist of oral oncolytics, and oncology programs are needed to manage the treatment of patients following these regimens.

Follow-up PET/CT more than 95% sensitive for non-Hodgkin lymphoma

BALTIMORE, MD—For more aggressive cases of non-Hodgkin lymphoma (NHL), posttreatment surveillance with molecular imaging could mean the early start of a new, life-saving treatment. This was presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2015 Annual Meeting.

Distinct triple-positive subtypes identified in breast cancer

CHICAGO, IL—Functional subtyping with a multigene classifier resulted in 1 in 5 tumors being reclassified compared with conventional immunohistochemistry/fluorescent in situ hybridization (IHC/FISH) analysis. This study was presented at the 2015 American Society for Clinical Oncology (ASCO) Annual Meeting.

Removing more breast tissue reduces the need for a second cancer surgery

Expanded surgical margins during a partial mastectomy could be beneficial for patients, preventing further surgery.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs